Ignite Creation Date:
2025-12-25 @ 2:32 AM
Ignite Modification Date:
2026-01-07 @ 2:09 PM
Study NCT ID:
NCT05986734
Status:
UNKNOWN
Last Update Posted:
2023-08-14
First Post:
2023-03-06
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Evaluation of Subcutaneous Immunoglobulin Product Cutaquig in Terms of Safety and Efficacy in the Treatment of Patients With Primary Immunodeficiencies
Sponsor:
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-09-01
Start Date Type:
ACTUAL
Primary Completion Date:
2023-07-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2023-12-01
Completion Date Type:
ESTIMATED
First Submit Date:
2023-03-06
First Submit QC Date:
None
Study First Post Date:
2023-08-14
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-08-08
Last Update Post Date:
2023-08-14
Last Update Post Date Type:
ACTUAL